- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT00510380
Epigenetic Markers in Growth Restricted Human Pregnancies: a Case-controlled Study
Epigenetic Markets in Growth Restricted Human Pregnancies: A Case- Control Study
This study is carried out to discover if a baby with restricted growth in the womb is subject to specific fetal programming which predisposes to the metabolic syndrome(diabetes,hypertension,heart disease) in adulthood.We have elected to first study this condition in Chinese population in Singapore with the eventual plan of studying all ethnic groups. This is important for understanding the molecular basis of adult-onset disease such as diabetes, identifying children at risk of developing this disease in future and targeting specific strategies for intervention and disease prevention.
Intrauterine fetal programming is effected through epigenetic changes similar to those previously identified in animal studies. The epigenetic markers can be found in growth restricted Chinese pregnancies in the local population.
Studieoversigt
Status
Betingelser
Detaljeret beskrivelse
Fetal growth restriction is associated with accelerated postnatal weight gain and increased obesity risk in later life.International epidemiological data suggest that the phenomenon of fetal programming links poor intrauterine growth to adult disease, primarily type II diabetes, obesity and metabolic syndrome, conditions increasingly common in Singapore. Suboptimal intrauterine environmental condition s are postulated to affect fetal development through effects on developmental plasticity through epigenetic processes. These effects manifest as poor glucose resistance, insulin resistance, obesity and cardiovascular disease in later life. There is increasing animal data to support this model.
The aim of this study is to determine if epigenetic markers of the metabolic syndrome are present in selected Chinese pregnancies in Singapore.
Hypothesis:
Intrauterine fetal programming is effected through epigenetic changes similar to those previously identified in animal studies. The epigenetic markers can be found in growth restricted Chinese pregnancies in the local population.
Methodology Umbilical cords and cord blood will be collected from twenty unequivocally growth-restricted Chinese pregnancies and twenty appropriately-grown Chinese pregnancies. DNA extracted from these tissues will be subjected to a custom-made DNA methylation array probing for specific changes in 262 candidate genes important to fetal endocrine and metabolic control.
This will be done using either a methylation array or a Sequenorn 2 in the DNA extracts that have been identified through Epigen academic consortium of the Liggins Institute and UK collaborators.
Anthropometric data will be collected from the infants at birth, and subsequently at 3,6,12,18 and 24 months and we will seek differential measures of programming.
Application The discovery of biomarkers indicating shifted developmental trajectories is the most important need in developmental programming research. Birth weight alone is not a valid measure. Biomarkers predictive of later obesity and the metabolic syndrome will be invaluable in formulating preventive strategies for these diseases.
Undersøgelsestype
Tilmelding (Forventet)
Kontakter og lokationer
Studiesteder
-
-
-
Singapore, Singapore, 119074
- National University Hospital
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Beskrivelse
Inclusion Criteria:
- Chinese women,
- Singleton pregnancies,
- fetal growth restriction diagnosed clinically and by ultrasound parameters,
- Normally grown fetuses by clinical and ultrasound criteria
Exclusion Criteria:
- Non-Chinese women
- Multiple pregnancies
- Co-existing antenatal complications including sever pre-eclampsia
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Kohorter og interventioner
Gruppe / kohorte |
---|
growth-restricted Chinese pregnancies
|
appropriately-grown Chinese pregnancies
|
Samarbejdspartnere og efterforskere
Efterforskere
- Ledende efterforsker: Yap Seng Chong, MBBS, National University Hospital, Singapore
Datoer for undersøgelser
Studer store datoer
Studiestart
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- SIG/07072
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Fostervæksthæmning
-
Assistance Publique - Hôpitaux de ParisRekrutteringIntrauterin vækstrestriktion | Fetal Growth Restriction (FGR)Frankrig
-
University of British ColumbiaAfsluttetIntrauterin vækstrestriktion (IUGR) | Fetal Growth Restriction (FGR)Canada
-
Inonu UniversityAfsluttetLyt til Fetal HeartbeatKalkun
-
Assiut UniversityMiddle-East Obstetrics and Gynecology Graduate Education (MOGGE) FoundationIkke rekrutterer endnu
-
Beni-Suef UniversityAfsluttet
-
China Medical University HospitalUkendtAfbrydelse af graviditet
-
Yonsei UniversityAfsluttetFibroblast Growth Factors (FGF'er)/Fibroblast Growth Factor Receptorer (FGFR'er) Genetisk aberration gastrisk cancer, INCB054828, PaclitaxelKorea, Republikken
-
Fondazione Policlinico Universitario Agostino Gemelli...Azienda Ospedaliero-Universitaria di Parma; Ministero della Salute, Italy; Ospedale Di Venere, ASL BA, Bari ItalyRekrutteringHjerne misdannelse | Fetal anomaliItalien